食品科学 ›› 2025, Vol. 46 ›› Issue (13): 159-136.doi: 10.7506/spkx1002-6630-20250102-011

• 营养卫生 • 上一篇    

母乳源Lactobacillus paragasseri HM018改善人源化妊娠小鼠肠道代谢

田小燕,赵军英,刘彦品,刘斌,张珍珍,赵育瑾,赵岩岩,袁玉莹,刘璐,王雅茹,乔为仓,陈历俊   

  1. (1.东北农业大学食品学院,黑龙江 哈尔滨 150030;2.北京三元食品股份有限公司,国家母婴乳品健康工程技术研究中心,北京市乳品工程技术研究中心,母乳研究技术创新中心,北京 100163;3.大连工业大学生物工程学院,辽宁 大连 116034;4.山东第二医科大学公共卫生学院,山东 潍坊 261042)
  • 发布日期:2025-06-13
  • 基金资助:
    国家自然科学基金面上项目(32072191);中央引导地方科技发展专项(桂科ZY22096025); 北京市科技计划课题(Z221100006422012);首农食品集团自立科技项目

Lactobacillus paragasseri HM018, Isolated from Human Milk, Improves Intestinal Metabolism in Germ-Free Mice Humanized with Gut Microbiota from Pregnant Women during Pregnancy

TIAN Xiaoyan, ZHAO Junying, LIU Yanpin, LIU Bin, ZHANG Zhenzhen, ZHAO Yujin, ZHAO Yanyan, YUAN Yuying, LIU Lu, WANG Yaru, QIAO Weicang, CHEN Lijun   

  1. (1. College of Food Science, Northeast Agricultural University, Harbin 150030, China;2. National Engineering Research Center of Dairy Health for Maternal and Child, Beijing Engineering Research Center of Dairy, Beijing Technical Innovation Center of Human Milk Research, Beijing Sanyuan Foods Co. Ltd., Beijing 100163, China; 3. School of Biological Engineering, Dalian Polytechnic University, Dalian 116034, China; 4. School of Public Health, Shandong Second Medical University, Weifang 261042, China)
  • Published:2025-06-13

摘要: 探究母乳源副格氏乳杆菌Lactobacillus paragasseri HM018对粪菌移植人源化妊娠小鼠肠道菌群及其代谢的影响。选取8 周龄无菌小鼠,移植健康孕妇的粪便菌悬液构建肠道菌群人源化无菌小鼠模型,受孕后,副格氏乳杆菌干预3 周。结果表明,与模型组相比,干预14 d时显著增加了人源化妊娠小鼠肠道微生物的Shannon指数和Simpson指数,增加了Roseburia和Clostridum的丰度和粪便中胆汁酸尤其是次级胆汁酸的含量。此外,显著改变了20 条代谢通路的37 种血清代谢物,其中显著上调了吡哆醇和肉豆蔻油酸含量,显著下调了壬酸含量,显著影响了胰高血糖素信号通路,有增加短链脂肪酸和色氨酸的趋势。本研究表明L. paragasseri HM018可改善肠道菌群和胆汁酸代谢,具有潜在的健康益处。

关键词: Lactobacillus paragasseri HM018;益生菌;肠道菌群;胆汁酸;代谢组学

Abstract: In this study, we investigated the effect of Lactobacillus paragasseri HM018 on the intestinal microbiota and metabolism in humanized pregnant mice with fecal microbiota transplantation. Eight-week-old germ-free mice were transplanted with fecal bacterial suspensions from healthy pregnant women to develop a germ-free humanized mouse model. After conception, the mice were treated by L. paragasseri HM018 for three weeks. The results showed that the Shannon and Simpson indexes of gut microbiota in the treatment group were higher significantly than those of the model group after 14 days. The abundance of Roseburia and Clostridium and the content of bile acids, especially secondary bile acids, in feces increased significantly in the treatment group compared with the model group. In addition, 37 serum metabolites involved in 20 metabolic pathways changed significantly, among which pyridoxine and myristoleic acid were up-regulated and pelargonic acid was down-regulated. In addition, L. paragasseri HM018 had significant effects on the glucagon signaling pathway and showed a tendency to increase short-chain fatty acids and tryptophan. This study shows that L. paragasseri HM018 improves gut microbiota and bile acid metabolism, thus having potential health benefits.

Key words: Lactobacillus paragasseri HM018; probiotics; gut microbiota; bile acids; metabolomics

中图分类号: